| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 759676 | 72635 | DOCETAXEL AUROVITAS 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | DOCETAXEL AUROVITAS 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 8 ml | 20 mg/ml inyectable 8 ml | 45 | 1 | 34 | 1 vial de 8 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72635/72635_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72635/72635_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38359 | AUROVITAS SPAIN, S.A.U. | 2011-01-10 | 1 | 1 | 1 | 2011-01-10 | 2022-12-02 | 1 | 2023-09-20 | View Edit Delete | ||||||||||||
| 728789 | 85174 | DOCETAXEL GLENMARK 20 MG/1 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOCETAXEL GLENMARK 20 MG/1 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 1 ml | 20 mg/ml inyectable 1 ml | 45 | 1 | 34 | 1 vial de 1 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85174/85174_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85174/85174_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28557 | GLENMARK FARMACEUTICA S.L.U | 2020-06-16 | 1 | 1 | 1 | 2020-06-17 | 2020-06-16 | 1 | 2023-09-14 | View Edit Delete | ||||||||||||
| 728790 | 85174 | DOCETAXEL GLENMARK 20 MG/1 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOCETAXEL GLENMARK 20 MG/1 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 4 ml | 20 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85174/85174_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85174/85174_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28557 | GLENMARK FARMACEUTICA S.L.U | 2020-06-16 | 1 | 1 | 1 | 2020-06-17 | 2020-06-16 | 1 | 2023-09-14 | View Edit Delete | ||||||||||||
| 728791 | 85174 | DOCETAXEL GLENMARK 20 MG/1 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOCETAXEL GLENMARK 20 MG/1 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 8 ml | 20 mg/ml inyectable 8 ml | 45 | 1 | 34 | 1 vial de 8 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85174/85174_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85174/85174_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28557 | GLENMARK FARMACEUTICA S.L.U | 2020-06-16 | 1 | 1 | 1 | 2020-06-17 | 2020-06-16 | 1 | 2023-09-14 | View Edit Delete | ||||||||||||
| 766240 | 89959 | DOCETAXEL HIKMA 160 MG/8 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOCETAXEL HIKMA 160 MG/8 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 8 ml | 160 mg inyectable perfusión 8 ml | 45 | 1 | 34 | 1 vial de 8 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89959/89959_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89959/89959_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14340 | HIKMA ESPAÑA, S.L.U. | 2025-01-07 | 1 | 1 | 1 | 2025-01-07 | 2025-01-07 | 1 | 2026-05-19 | View Edit Delete | ||||||||||||
| 667213 | 71799 | DOCETAXEL HOSPIRA 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | DOCETAXEL HOSPIRA 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 8 ml | 10 mg/ml inyectable 8 ml | 45 | 1 | 34 | 1 vial de 8 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71799/71799_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71799/71799_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11622 | PFIZER S.L. | 2010-04-13 | 1 | 1 | 1 | 2010-04-13 | 2010-04-13 | 1 | 2011-09-02 | View Edit Delete | ||||||||||||
| 667214 | 71799 | DOCETAXEL HOSPIRA 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | DOCETAXEL HOSPIRA 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 16 ml | 10 mg/ml inyectable 16 ml | 45 | 1 | 34 | 1 vial de 16 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71799/71799_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71799/71799_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11622 | PFIZER S.L. | 2010-04-13 | 1 | 1 | 1 | 2010-04-13 | 2010-04-13 | 1 | 2011-09-02 | View Edit Delete | ||||||||||||
| 732216 | 86406 | DOCETAXEL SEACROSS 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOCETAXEL SEACROSS 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 1 ml | 20 mg/ml inyectable 1 ml | 45 | 1 | 34 | 1 vial de 1 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86406/86406_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86406/86406_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41980 | SUN PHARMA LABORATORIOS S.L. | 2022-04-19 | 1 | 1 | 1 | 2022-04-19 | 2022-04-19 | 1 | 2025-02-04 | View Edit Delete | ||||||||||||
| 732217 | 86406 | DOCETAXEL SEACROSS 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOCETAXEL SEACROSS 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 4 ml | 20 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86406/86406_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86406/86406_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41980 | SUN PHARMA LABORATORIOS S.L. | 2022-04-19 | 1 | 1 | 1 | 2022-04-19 | 2022-04-19 | 1 | 2025-02-04 | View Edit Delete | ||||||||||||
| 734014 | 86406 | DOCETAXEL SEACROSS 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOCETAXEL SEACROSS 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 8 ml | 20 mg/ml inyectable 8 ml | 45 | 1 | 34 | 1 vial de 8 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86406/86406_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86406/86406_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41980 | SUN PHARMA LABORATORIOS S.L. | 2022-04-19 | 1 | 1 | 1 | 2022-04-19 | 2022-04-19 | 1 | 2025-02-04 | View Edit Delete | ||||||||||||
| 700622 | 48557 | DOGMATIL 50 mg/ml SOLUCION INYECTABLE | DOGMATIL 50 mg/ml SOLUCION INYECTABLE , 12 ampollas de 2 ml | 100 mg inyectable 2 ml | 1 | 12 | 1 | 12 ampollas de 2 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/48557/48557_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/48557/48557_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 1969-10-01 | 1 | 1 | 1 | 1969-10-01 | 2015-12-09 | 1 | 2011-06-09 | 746784 | View Edit Delete | |||||||||||
| 693911 | 48558 | DOGMATIL FUERTE 200 mg COMPRIMIDOS | DOGMATIL FUERTE 200 mg COMPRIMIDOS , 36 comprimidos | 200 mg | 5 | 36 | 10 | 36 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/48558/48558_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/48558/48558_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 1969-10-01 | 1 | 1 | 1 | 1969-10-01 | 1994-03-01 | 1 | 2011-06-09 | View Edit Delete | ||||||||||||
| 913368 | 59357 | DOLAK RETARD 60 mg COMPRIMIDOS DE LIBERACION PROLONGADA | DOLAK RETARD 60 mg COMPRIMIDOS DE LIBERACION PROLONGADA, 30 comprimidos | 60 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59357/59357_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59357/59357_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 71209 | ALFASIGMA ESPANA S.L. | 1992-10-01 | 1 | 1 | 1 | 1992-10-01 | 1992-10-01 | 1 | 2011-10-26 | View Edit Delete | ||||||||||||
| 683748 | 52738 | DOLALGIAL CLONIXINO LISINA 125 mg COMPRIMIDOS RECUBIERTOS | DOLALGIAL CLONIXINO LISINA 125 mg COMPRIMIDOS RECUBIERTOS , 20 comprimidos | 125 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/52738/52738_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/52738/52738_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 1975-02-01 | 1 | 1 | 1 | 1975-02-01 | 1995-06-01 | 0 | 2011-06-09 | 746834 | View Edit Delete | |||||||||||
| 700770 | 24245 | DOLANTINA 50 mg/ml SOLUCION INYECTABLE | DOLANTINA 50 mg/ml SOLUCION INYECTABLE , 10 ampollas de 1 ml | 50 mg/ml inyectable 1 ml | 1 | 10 | 1 | 10 ampollas de 1 ml | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/24245/24245_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/24245/24245_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 1955-07-01 | 1 | 1 | 1 | 1955-07-01 | 2013-12-03 | 0 | 2015-03-20 | Lista I | View Edit Delete | |||||||||||
| 795062 | 24245 | DOLANTINA 50 mg/ml SOLUCION INYECTABLE | DOLANTINA 50 mg/ml SOLUCION INYECTABLE , 10 ampollas de 2 ml | 50 mg /ml inyectable 2 ml | 1 | 10 | 1 | 10 ampollas de 2 ml | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/24245/24245_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/24245/24245_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 1955-07-01 | 1 | 1 | 1 | 1955-07-01 | 2003-12-23 | 0 | 2011-10-17 | 652693 | Lista I | View Edit Delete | ||||||||||
| 795351 | 24245 | DOLANTINA 50 mg/ml SOLUCION INYECTABLE | DOLANTINA 50 mg/ml SOLUCION INYECTABLE , 1 ampolla de 2 ml | 50 mg /ml inyectable 2 ml | 1 | 1 | 1 | 1 ampolla de 2 ml | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/24245/24245_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/24245/24245_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 1955-07-01 | 1 | 1 | 1 | 1955-07-01 | 2004-01-15 | 0 | 2011-10-17 | 975045 | Lista I | View Edit Delete | ||||||||||
| 722035 | 83195 | DOLENGRIP 650 MG/15,58 MG/4 MG GRANULADO PARA SOLUCION ORAL | DOLENGRIP 650 MG/15,58 MG/4 MG GRANULADO PARA SOLUCION ORAL 10 sobres | 650 mg/ 15,58 mg/4 mg | 35 | 10 | 64 | 10 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83195/83195_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83195/83195_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | TECNIMEDE ESPAÑA INDUSTRIA FARMACEUTICA S.A. | 2018-06-07 | 1 | 1 | 1 | 2018-06-08 | 2018-06-07 | 1 | 2019-06-03 | View Edit Delete | ||||||||||||
| 918979 | 59391 | DOLIFEN 11,6 MG/G GEL | DOLIFEN 11,6 MG/G GEL , 1 tubo de 60 g | 10 mg/g | 44 | 60 | 21 | 1 tubo de 60 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59391/59391_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59391/59391_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41329 | FAES FARMA S.A. | 1992-06-01 | 1 | 1 | 1 | 1992-06-01 | 1992-06-01 | 1 | 2011-10-26 | View Edit Delete | ||||||||||||
| 702405 | 65823 | DOLINTOL 20 mg CÁPSULAS DURAS GASTRORRESISTENTES EFG | DOLINTOL 20 mg CÁPSULAS DURAS GASTRORRESISTENTES EFG , 14 cápsulas | 20 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65823/65823_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65823/65823_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15730 | ABABOR PHARMACEUTICALS S.L. | 2003-12-16 | 1 | 1 | 1 | 2003-12-17 | 2014-05-22 | 1 | 2018-10-02 | 789214 | View Edit Delete |
Page 270 of 1036, showing 20 records out of 20702 total, starting on record 5381, ending on 5400